异种移植物与同种移植物主动脉根部置换的远期生存:前瞻性随机试验结果
该前瞻性随机试验纳入166例需主动脉瓣手术患者,比较Freestyle生物瓣(N=90)与同种移植物(N=76)全根部主动脉瓣置换的远期生存。中位随访13.8年,20年生存率Freestyle组28.3%±5% vs 同种移植物组25.1%±5.7%(P=.90),20年免于主动脉瓣再手术率两组相当(67.9%±8.8% vs 67.2%±10.3%,P=.74)。
要点
- 两组20年总体生存率无显著差异,且与年龄性别匹配的英国一般人群相当。
- 20年免于主动脉瓣再手术率两组无显著差异。
- 该研究为老年主动脉瓣疾病干预的未来研究提供了基准。
核心结论
- 异种移植物与同种移植物全根部主动脉瓣置换的20年总体生存率和免于再手术率无显著差异。
研究设计与样本
- 单中心前瞻性随机试验,1997至2005年纳入166例需主动脉瓣手术患者,随机分配至Freestyle生物瓣(N=90)或同种移植物(N=76)全根部主动脉瓣置换。
- 6例随机分配至同种移植物组患者因无合适尺寸同种移植物而交叉至Freestyle生物瓣。
- 随访完成率98.5%,中位随访13.8年(范围0-21.8年;2033患者年)。
主要发现
- 研究人群平均年龄65±8岁。
- 166例中76例(46%)同时行冠状动脉旁路移植术,组间差异无统计学意义。
- 总体住院死亡率为4.8%(8/166),组间差异无统计学意义。
- Kaplan-Meier生存分析显示两组5年、10年和15年总体生存率无显著差异。
- 20年生存率Freestyle组28.3%±5% vs 同种移植物组25.1%±5.7%(P=.90),与年龄和性别匹配的英国一般人群相当。
关键数值与推荐
- 20年生存率:Freestyle组28.3%±5%,同种移植物组25.1%±5.7%(P=.90)。
- 20年免于主动脉瓣再手术率:Freestyle组67.9%±8.8%,同种移植物组67.2%±10.3%(P=.74)。
- 总体住院死亡率4.8%(8/166)。
临床怎么用
- 对于需全根部主动脉瓣置换的患者,异种移植物与同种移植物在远期生存和再手术方面表现相当,选择时可综合考虑移植物可用性和患者因素。
- 该研究提供的20年生存和再手术基准可用于咨询老年主动脉瓣疾病患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The study objective was to investigate the long-term survival of patients undergoing xenograft versus homograft full root aortic valve replacement. METHODS: A total of 166 patients requiring aortic valve surgery were randomized to undergo the Freestyle (Medtronic Inc, Minneapolis, Minn) bioprosthesis (N = 90) or a homograft (N = 76) full root aortic valve replacement between 1997 and 2005 in a single institution. Six patients randomly assigned to the homograft crossed over to the Freestyle bioprosthesis because of the unavailability of suitably sized homografts. All surgeons were required to adhere to the standard surgical technique for homograft root implantation previously described. Follow-up was 98.5% complete. RESULTS: The mean age of the study population was 65 ± 8 years. Coronary artery bypass grafting was associated with root aortic valve replacement in 76 of 166 patients (46%, P = not significant between groups), and overall hospital mortality was 4.8% (8/166, P = not significant between groups). Median follow-up was 13.8 years (range, 0-21.8 years; 2033 patient-years). The Kaplan-Meier survival analysis showed that there was no significant difference in overall survival between the 2 arms at 5, 10, and 15 years. Twenty-year survival was 28.3% ± 5% for the Freestyle group versus 25.1% ± 5.7% for the homograft group (P = .90), which was comparable to the age- and sex-matched UK general population. The freedom from aortic valve reoperation at 20 years was comparable for the Freestyle group versus the homograft group (67.9% ± 8.8% vs 67.2% ± 10.3%, respectively; P = .74). CONCLUSIONS: This is the first study to investigate the long-term survival of xenograft versus homograft full root aortic valve replacement from a prospective randomized trial. The observed 20-year overall survival and freedom from aortic valve reoperation serve as a benchmark for future studies on interventions for aortic valve disease in the elderly.
引用
- Melina G, De Robertis F, Gaer JA, et al. Long-term survival after xenograft versus homograft aortic root replacement: Results from a prospective randomized trial. J Thorac Cardiovasc Surg. 2019. PMID: 31735388. doi:10.1016/j.jtcvs.2019.09.119
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。